Missouri 2023 Regular Session

Missouri House Bill HB1286

Introduced
2/27/23  
Refer
4/4/23  
Report Pass
4/24/23  

Caption

Creates provisions relating to voluntary nonopioid directive forms

Impact

If enacted, HB 1286 would modify existing healthcare regulations to accommodate and formalize the use of nonopioid directives. This change implies that healthcare providers would be required to recognize and honor patient preferences concerning pain relief. It signifies a shift in the healthcare approach, allowing patients to have more say in their treatment options and potentially leading to a broader cultural change in how pain management is approached within the state. Overall, it aims to create a more patient-centered healthcare environment that recognizes the risks associated with opioid usage.

Summary

House Bill 1286 aims to establish provisions regarding voluntary nonopioid directive forms. This legislation is part of a broader effort to address the ongoing opioid crisis by empowering patients to express their preferences for nonopioid pain management options. By allowing individuals to specify their desire to avoid opioid prescriptions, the bill seeks to promote patient autonomy and enhance informed decision-making in pain management. Supporters of the bill believe that this will contribute to reducing reliance on opioids and ultimately help curb addiction rates.

Sentiment

The sentiment around HB 1286 has been generally positive among healthcare advocates and patient rights groups, who view the bill as a progressive step toward enhancing individual rights in medical treatments. Proponents argue that it aligns with current healthcare trends emphasizing personalized medicine. On the other hand, some healthcare providers express concerns over the practicality and implementation of such directives, fearing it might lead to complexities in pain management protocols. Nonetheless, the general atmosphere surrounding the bill suggests strong support from various stakeholders who prioritize patient choice.

Contention

The primary point of contention regarding HB 1286 relates to the practical implications of enforcing nonopioid directives within existing healthcare frameworks. Critics highlight potential challenges, such as ensuring that healthcare providers are adequately informed about these directives and can effectively incorporate them into treatment plans. Additionally, there are concerns that some patients may feel pressured to refuse opioid prescriptions, potentially hindering their access to necessary pain relief. Thus, while the intentions behind the bill are broadly supported, its execution and implications remain points of active debate among healthcare professionals and lawmakers.

Companion Bills

No companion bills found.

Previously Filed As

MO H1081

Voluntary Nonopioid Advance Directive Forms

MO SB663

Establishes procedures for voluntary nonopioid directives

MO A5595

Permits individuals to establish voluntary nonopioid directives.

MO S4337

Permits individuals to establish voluntary nonopioid directives.

MO SB90

Provides relative to a voluntary nonopioid directive form. (8/1/18) (EN SEE FISC NOTE SG RV See Note)

MO S0714

Nonopioid Advance Directives

MO HB737

Public Health - Nonopioid Advance Directives

MO SB598

Relating to step therapy for nonopioids.

MO SF1814

Nonopioid directives usage authorization provision and certain acts of failure to act immunity establishment provision

MO HB2085

Relating to general procedures and requirements for a nonopioid directive.

Similar Bills

No similar bills found.